Last reviewed · How we verify
NCT07236736: SPMT
Evaluation of SPM™ Topical Cosmetic Application on Skin Appearance, Hydration, and Barrier Support in Healthy Adults
NA trial testing Skin biopsy in Healthy Skin in 10 participants. Not yet recruiting.
5 December 2026
Quick facts
| Lead sponsor | Biocoz Global Pte. Ltd. |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 10 |
| Start date | 30 January 2026 |
| Primary completion | 5 December 2026 |
| Estimated completion | 30 June 2027 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Skin biopsy
- Corneometer® Measurement
- Tewameter® Measurement
Conditions studied
- Healthy Skin — all drugs for Healthy Skin →
- Skin Hydration — all drugs for Skin Hydration →
Sponsor
Biocoz Global Pte. Ltd.
Who can join
Adults 20 to 75, any sex, with Healthy Skin or Skin Hydration. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is an exploratory, cosmetic-use study evaluating the effects of Super Protein Multifunction (SPM™), a topical peptide-based formulation, on skin appearance, hydration, and barrier-related characteristics in healthy adults. The study aims to collect preliminary biophysical and histologic data on cosmetic skin changes following six weeks of SPM™ use. Participants will apply the product to a designated skin area while a matched contralateral area serves as the untreated comparison site. Skin hydration, transepidermal water loss (TEWL), and tissue markers of skin structure and barrier integrity will be assessed before and after product use. The study includes noninvasive measurements and small punch biopsies at two timepoints.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07236736
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Skin biopsy
Trials testing the same drug.
- NCT07049588 — Identification of Novel Biomarkers in Early Charcot-Marie-Tooth 1A Disease · NA · recruiting
- NCT06539351 — A Pilot Study to Finetune Skin Processing Procedures in Recent Vaccinees, Prior to GeKoSkimm Study Initiation (GeKoSkimm · NA · completed
- NCT06467461 — Identification of Prodromal Neurodegeneration in Serotonergic-Induced REM Sleep Behavior Disorder · NA · recruiting
- NCT04872452 — Analysis of Cutaneous Nerve Biopsies in Gastrointestinal Motility Disorders · NA · withdrawn
- NCT05660421 — Itacitinib for the Treatment Steroid Refractory Immune Related Adverse Events Arising From Immune Checkpoint Inhibitors · Phase 2 · withdrawn
Other recruiting trials for Healthy Skin
Currently open trials in the same condition.
- NCT07091604 — An Observational Study to Assess Objective Skin Pigmentation Variation. · recruiting
- NCT06440473 — Visualization of Topical Zoryve vs. Vehicle Using Line Field Optical Coherence Tomography in Healthy Skin · Phase 4 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07236736 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Biocoz Global Pte. Ltd.
- Last refreshed: 19 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07236736.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing